{"id":2139,"date":"2026-09-02T12:52:52","date_gmt":"2026-09-02T19:52:52","guid":{"rendered":"https:\/\/www.ultalabtests.com\/blog\/?p=2139"},"modified":"2026-09-02T12:52:55","modified_gmt":"2026-09-02T19:52:55","slug":"key-symptoms-of-pancreatic-cancer-to-watch-for","status":"publish","type":"post","link":"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/","title":{"rendered":"Pancreatic Cancer Symptoms and Testing: What Blood Tests Can\u2014and Cannot Detect"},"content":{"rendered":"\n<!-- WORDPRESS TITLE FIELD \/ H1: Pancreatic Cancer Symptoms and Testing: What Blood Tests Can\u2014and Cannot Detect -->\n<!-- Paste this entire file into the WordPress Gutenberg Code editor, not into a single Custom HTML block. -->\n\n<style>\n\/* Table borders and spacing for this Gutenberg article. Typography remains inherited\n   from the WordPress editor\/theme so headings, paragraphs, and table text stay adjustable. *\/\n.wp-block-table {\n  display: block;\n  width: 100%;\n  margin: 1.5rem 0;\n  overflow-x: auto;\n  -webkit-overflow-scrolling: touch;\n}\n.wp-block-table table {\n  width: 100%;\n  border-collapse: collapse !important;\n  border-spacing: 0 !important;\n  table-layout: auto;\n}\n.wp-block-table th,\n.wp-block-table td {\n  border: 1px solid #aebfc4 !important;\n  padding: 0.75rem 0.875rem !important;\n  text-align: left;\n  vertical-align: top;\n  overflow-wrap: break-word;\n  word-break: normal;\n}\n.wp-block-table thead th {\n  background: #1f4e5f !important;\n  color: #ffffff !important;\n  font-weight: 700;\n}\n.wp-block-table tbody th[scope=\"row\"] {\n  background: #e9f3f4 !important;\n  color: #1f4e5f !important;\n  font-weight: 700;\n}\n.wp-block-table tbody tr:nth-child(even) td {\n  background: #f7fafb;\n}\n.wp-block-table figcaption {\n  margin-top: 0.5rem;\n  color: #5f6a6e;\n  text-align: left;\n}\naside.wp-block-group {\n  margin: 1.5rem 0;\n  padding: 1.25rem 1.5rem;\n  border-left: 5px solid #e86f4a;\n  background: #fff6f2;\n}\naside.wp-block-group > :first-child {\n  margin-top: 0;\n}\n.wp-block-image img {\n  max-width: 100%;\n  height: auto;\n}\n.wp-block-image figcaption {\n  color: #5f6a6e;\n}\n@media (max-width: 781px) {\n  .wp-block-table table {\n    min-width: 720px;\n  }\n  .wp-block-table th,\n  .wp-block-table td {\n    padding: 0.625rem 0.75rem !important;\n  }\n}\n<\/style>\n\n<!-- SOCIAL-SHARING IMAGE: Set this URL in the SEO\/social-image field; do not render it in the article body: https:\/\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/09\/pancreatic-cancer-testing-social.webp -->\n\n\n\n<figure class=\"wp-block-image size-full\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1600\" height=\"900\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-blood-tests-hero.webp?resize=1600%2C900&#038;quality=100&#038;ssl=1\" alt=\"Clinician and patient review test information beside an illustrated pancreas and abdominal scan.\" class=\"wp-image-4060\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-blood-tests-hero.webp?w=1600&amp;quality=100&amp;ssl=1 1600w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-blood-tests-hero.webp?resize=300%2C169&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-blood-tests-hero.webp?resize=1024%2C576&amp;quality=100&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-blood-tests-hero.webp?resize=768%2C432&amp;quality=100&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-blood-tests-hero.webp?resize=1536%2C864&amp;quality=100&amp;ssl=1 1536w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"wp-element-caption\">Blood tests can reveal patterns that support a pancreatic evaluation, but imaging and sometimes tissue sampling are needed to answer diagnostic questions.<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Direct answer:<\/strong> No routine blood test can reliably screen the general population for pancreatic cancer, diagnose it by itself, or rule it out. Blood tests can reveal jaundice-related bile-flow abnormalities, anemia, metabolic changes, or pancreatic injury. In selected patients, tumor markers may add context after professional evaluation or help monitor known disease. Pancreatic cancer is usually evaluated with a clinical assessment and dedicated imaging; endoscopic ultrasound and tissue sampling may be needed. A normal blood result should never delay evaluation of persistent jaundice, unexplained weight loss, or progressive upper-abdominal or back pain.<sup><a href=\"#ref-1\" aria-label=\"Reference 1\">[1]<\/a><\/sup><sup><a href=\"#ref-2\" aria-label=\"Reference 2\">[2]<\/a><\/sup><\/p>\n\n\n\n<aside class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"urgent-symptoms-heading\" class=\"wp-block-heading\">Urgent symptoms: do not wait for an outpatient lab result<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Seek prompt medical assessment for new jaundice, dark urine with pale or clay-colored stool, unexplained weight loss, or persistent upper-abdominal or back pain. Seek urgent or emergency care for jaundice with fever or chills, confusion, fainting, severe or rapidly worsening pain, repeated vomiting, inability to keep fluids down, black or bloody stool, or vomiting blood. Direct-access laboratory testing is not an emergency service and cannot replace an examination or time-sensitive imaging.<\/p>\n<\/div><\/aside>\n\n\n\n<section class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"key-takeaways-heading\" class=\"wp-block-heading\">Key takeaways<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>No blood test is recommended as routine pancreatic-cancer screening for average-risk adults without symptoms.<\/li>\n\n\n\n<li>Jaundice, unexplained weight loss, progressive upper-abdominal or back pain, pale or greasy stool, and new metabolic changes deserve professional evaluation, but none is specific to cancer.<\/li>\n\n\n\n<li>Blood tests may identify complications or clues, such as a bile-duct obstruction pattern, anemia, altered glucose regulation, or acute pancreatic injury.<\/li>\n\n\n\n<li><a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a> and <a href=\"https:\/\/www.ultalabtests.com\/test\/CEA\">CEA<\/a> are not stand-alone screening or diagnostic tests. Their most defensible uses are specialist-selected evaluation and monitoring in known disease.<\/li>\n\n\n\n<li><a href=\"https:\/\/www.ultalabtests.com\/test\/lipase\">Lipase<\/a> and <a href=\"https:\/\/www.ultalabtests.com\/test\/amylase\">amylase<\/a> can support an acute-pancreatitis evaluation; they do not detect pancreatic cancer.<\/li>\n\n\n\n<li>Dedicated imaging, sometimes followed by endoscopic ultrasound and tissue sampling, is what usually establishes or excludes a pancreatic mass and defines next steps.<\/li>\n<\/ul>\n<\/div><\/section>\n\n\n\n<section class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"knowledge-center-heading\" class=\"wp-block-heading\">Part of the Ulta Lab Tests Knowledge Center<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">This article belongs primarily to the <a href=\"https:\/\/www.ultalabtests.com\/blog\/cancer\/cancer-blood-tests-and-tumor-markers-uses-limitations-and-follow-upcancer-blood-tests-tumor-markers\/\">Cancer Blood Tests and Tumor Markers: Uses, Limits, and Next Steps<\/a> pillar. Use the <a href=\"https:\/\/www.ultalabtests.com\/blog\/digestive-system\/digestive-health-lab-tests\/\">Digestive Health Lab Tests<\/a> pillar for the broader digestive-testing pathway, the <a href=\"https:\/\/www.ultalabtests.com\/blog\/liver\/liver-health-metabolic-dashboard-lab-tests\/\">Liver Health as a Metabolic Dashboard<\/a> pillar for jaundice and liver-associated patterns, and <a href=\"https:\/\/www.ultalabtests.com\/blog\/digestive-system\/pancreatic-diseases\/understanding-pancreatitis-symptoms-causes-pancreatic-cancer\/\">Understanding Pancreatitis<\/a> for the acute and chronic pancreatic-inflammation differential.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For foundational guidance, see <a href=\"https:\/\/www.ultalabtests.com\/blog\/lab-testing-knowledge-center\/complete-guide-to-lab-tests-and-blood-work\/\">The Complete Guide to Lab Tests and Blood Work<\/a>, <a href=\"https:\/\/www.ultalabtests.com\/blog\/lab-testing-knowledge-center\/how-to-read-lab-results\/\">How to Read and Understand Your Lab Results<\/a>, and <a href=\"https:\/\/www.ultalabtests.com\/blog\/lab-testing-knowledge-center\/direct-access-lab-testing\/\">Direct-Access Lab Testing: How It Works and What to Expect<\/a>.<\/p>\n<\/div><\/section>\n\n\n\n<nav class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 class=\"wp-block-heading\">On this page<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"#what-is-pancreatic-cancer\">What pancreatic cancer is<\/a><\/li>\n\n\n\n<li><a href=\"#symptoms\">Symptoms and warning patterns<\/a><\/li>\n\n\n\n<li><a href=\"#what-blood-tests-show\">What blood tests may show<\/a><\/li>\n\n\n\n<li><a href=\"#tumor-marker-limits\">Limits of CA 19-9 and CEA<\/a><\/li>\n\n\n\n<li><a href=\"#diagnosis\">What usually establishes the diagnosis<\/a><\/li>\n\n\n\n<li><a href=\"#high-risk-surveillance\">High-risk surveillance<\/a><\/li>\n\n\n\n<li><a href=\"#preparation\">Preparation and result influences<\/a><\/li>\n\n\n\n<li><a href=\"#results\">How to interpret results<\/a><\/li>\n\n\n\n<li><a href=\"#faq\">Frequently asked questions<\/a><\/li>\n<\/ul>\n<\/div><\/nav>\n\n\n\n<section id=\"what-is-pancreatic-cancer\" class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"what-is-pancreatic-cancer-heading\" class=\"wp-block-heading\">What is pancreatic cancer?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The pancreas sits deep in the upper abdomen, behind the stomach. Its exocrine cells produce digestive enzymes, while its endocrine cells produce hormones involved in blood-glucose regulation. Most pancreatic cancers begin in exocrine cells. Pancreatic neuroendocrine tumors are a different group of diseases with different biology, testing, and treatment; they should not be folded into a general pancreatic-cancer blood-test panel.<sup><a href=\"#ref-2\" aria-label=\"Reference 2\">[2]<\/a><\/sup><\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreas-upper-abdomen-anatomy.webp?resize=1024%2C1024&#038;quality=100&#038;ssl=1\" alt=\"Pancreas highlighted in orange within the upper abdomen behind the stomach and near the intestines.\" class=\"wp-image-4058\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreas-upper-abdomen-anatomy.webp?w=1024&amp;quality=100&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreas-upper-abdomen-anatomy.webp?resize=300%2C300&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreas-upper-abdomen-anatomy.webp?resize=150%2C150&amp;quality=100&amp;ssl=1 150w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreas-upper-abdomen-anatomy.webp?resize=768%2C768&amp;quality=100&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreas-upper-abdomen-anatomy.webp?resize=600%2C600&amp;quality=100&amp;ssl=1 600w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"wp-element-caption\">The pancreas lies deep behind the stomach, which is one reason symptoms can overlap with other digestive and biliary conditions.<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Early pancreatic cancer may cause no obvious symptoms. When symptoms develop, they often overlap with gallstones, hepatitis, pancreatitis, ulcers, medication effects, diabetes, and other digestive or metabolic conditions. That overlap is why symptoms and laboratory results must be interpreted together\u2014and why imaging is central when a structural pancreatic or bile-duct problem is possible.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Risk factors are not a diagnosis<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Smoking, excess body weight, diabetes, chronic pancreatitis, a family history of pancreatic cancer, and selected inherited syndromes can increase risk. Many people with one or more risk factors never develop pancreatic cancer, and some people who develop it have no recognized risk factor. Risk informs the evaluation; it does not convert a nonspecific symptom or abnormal blood result into a cancer diagnosis.<sup><a href=\"#ref-2\" aria-label=\"Reference 2\">[2]<\/a><\/sup><\/p>\n<\/div><\/section>\n\n\n\n<section id=\"symptoms\" class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"symptoms-heading\" class=\"wp-block-heading\">Pancreatic cancer symptoms and warning patterns<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The pattern, persistence, progression, and combination of symptoms matter more than any one symptom. The following findings should prompt clinical attention, especially when they are new, unexplained, or worsening.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/upper-abdominal-discomfort-medical-evaluation.webp?resize=1024%2C1024&#038;quality=100&#038;ssl=1\" alt=\"Adult woman holds her upper abdomen while experiencing discomfort that warrants medical evaluation if persistent or worsening.\" class=\"wp-image-4057\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/upper-abdominal-discomfort-medical-evaluation.webp?w=1024&amp;quality=100&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/upper-abdominal-discomfort-medical-evaluation.webp?resize=300%2C300&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/upper-abdominal-discomfort-medical-evaluation.webp?resize=150%2C150&amp;quality=100&amp;ssl=1 150w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/upper-abdominal-discomfort-medical-evaluation.webp?resize=768%2C768&amp;quality=100&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/upper-abdominal-discomfort-medical-evaluation.webp?resize=600%2C600&amp;quality=100&amp;ssl=1 600w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"wp-element-caption\">Upper-abdominal discomfort has many possible causes. Persistent, progressive, severe, or combined symptoms should be assessed by a qualified clinician.<\/figcaption><\/figure>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th scope=\"col\">Symptom or pattern<\/th><th scope=\"col\">Why it matters<\/th><th scope=\"col\">Other possible causes and next step<\/th><\/tr><\/thead><tbody><tr><th scope=\"row\">Jaundice, dark urine, pale stool, or itching<\/th><td>A blockage in bile flow can raise bilirubin and cause yellowing of the eyes or skin.<\/td><td>Gallstones, hepatitis, medication-related injury, inflammation, strictures, and other liver or bile-duct conditions can look similar. New jaundice warrants prompt medical evaluation and usually imaging.<\/td><\/tr><tr><th scope=\"row\">Persistent upper-abdominal pain or pain extending to the back<\/th><td>Pancreatic and nearby structures can produce overlapping upper-abdominal and back-pain patterns.<\/td><td>Pancreatitis, gallbladder disease, ulcers, reflux, muscle or spine conditions, vascular emergencies, and even heart disease can cause similar pain. Severe or rapidly worsening pain is urgent.<\/td><\/tr><tr><th scope=\"row\">Unexplained weight loss, reduced appetite, or early fullness<\/th><td>These may reflect impaired intake, malabsorption, metabolic change, inflammation, or advanced illness.<\/td><td>Digestive disorders, thyroid disease, depression, medication effects, infection, and many cancers can cause weight loss. A clinician should evaluate persistent unintentional loss.<\/td><\/tr><tr><th scope=\"row\">Pale, greasy, floating, or difficult-to-flush stool<\/th><td>Fat malabsorption can occur when pancreatic enzyme delivery or bile flow is impaired.<\/td><td>Exocrine pancreatic insufficiency, celiac disease, small-bowel disease, bile-flow disorders, and diet can contribute. Stool testing, imaging, or gastroenterology review may be appropriate.<\/td><\/tr><tr><th scope=\"row\">Nausea, vomiting, or worsening intolerance of meals<\/th><td>These symptoms may accompany inflammation, obstruction, metabolic disturbance, or another abdominal process.<\/td><td>Infection, medication effects, ulcers, gallbladder disease, pancreatitis, bowel obstruction, and many other conditions are more common. Persistent vomiting or dehydration requires urgent care.<\/td><\/tr><tr><th scope=\"row\">New or unexpectedly worsening blood-glucose abnormalities<\/th><td>The pancreas participates in glucose regulation, and metabolic change may be part of the clinical context.<\/td><td>Type 2 diabetes is common and usually is not caused by pancreatic cancer. New diabetes should receive standard clinical evaluation; it does not automatically justify self-directed tumor-marker testing.<\/td><\/tr><tr><th scope=\"row\">Fatigue, weakness, or pallor<\/th><td>Anemia, inflammation, poor intake, dehydration, or metabolic disruption may contribute.<\/td><td>These are highly nonspecific symptoms. Blood counts and chemistry tests may identify a complication but not its cause.<\/td><\/tr><\/tbody><\/table><figcaption class=\"wp-element-caption\">Symptoms that may occur with pancreatic cancer\u2014and important alternative explanations<\/figcaption><\/figure>\n<\/div><\/section>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-warning-symptoms.webp?resize=1024%2C768&#038;quality=100&#038;ssl=1\" alt=\"Six pancreatic warning patterns include jaundice, persistent upper-abdominal or back pain, weight loss, greasy stool, vomiting, and glucose changes.\" class=\"wp-image-4051\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-warning-symptoms.webp?resize=1024%2C768&amp;quality=100&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-warning-symptoms.webp?resize=300%2C225&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-warning-symptoms.webp?resize=768%2C576&amp;quality=100&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-warning-symptoms.webp?resize=1536%2C1152&amp;quality=100&amp;ssl=1 1536w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-warning-symptoms.webp?w=1600&amp;quality=100&amp;ssl=1 1600w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"wp-element-caption\">No symptom proves pancreatic cancer. New, persistent, unexplained, or worsening combinations\u2014especially jaundice, weight loss, pain, or dehydration\u2014need timely clinical evaluation.<\/figcaption><\/figure>\n\n\n\n<section id=\"what-blood-tests-show\" class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"what-blood-tests-show-heading\" class=\"wp-block-heading\">What blood tests may show\u2014and what they cannot establish<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Blood testing can help answer focused questions: Is there a bile-flow pattern? Is anemia present? Is glucose regulation changing? Is there evidence of acute pancreatic injury? Is a previously informative tumor marker changing during specialist-managed care? Those are support questions, not stand-alone cancer detection.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th scope=\"col\">Test and use status<\/th><th scope=\"col\">What it may show<\/th><th scope=\"col\">What it cannot show by itself<\/th><\/tr><\/thead><tbody><tr><th scope=\"row\"><a href=\"https:\/\/www.ultalabtests.com\/test\/liver-function-panel-test\">Liver Function Panel<\/a>, <a href=\"https:\/\/www.ultalabtests.com\/test\/bilirubin-total\">Bilirubin Total<\/a>, and <a href=\"https:\/\/www.ultalabtests.com\/test\/bilirubin-direct-test\">Bilirubin Direct<\/a><br>Common or symptom-directed<\/th><td>May reveal elevated bilirubin and a liver-associated pattern compatible with impaired bile flow. This is especially relevant with jaundice, dark urine, pale stool, or itching.<\/td><td>Cannot identify the location or cause of an obstruction, distinguish a stone from inflammation or a tumor, visualize the bile ducts, or diagnose pancreatic cancer.<\/td><\/tr><tr><th scope=\"row\"><a href=\"https:\/\/www.ultalabtests.com\/test\/complete-blood-count-with-differential-and-platelets-cbc-test\">Complete Blood Count with Differential and Platelets<\/a><br>Common or symptom-directed<\/th><td>May identify anemia, white-cell changes, or platelet abnormalities that add context or reveal a complication.<\/td><td>Cannot locate a tumor or determine why a blood-cell count is abnormal. Many people with pancreatic cancer have no distinctive blood-count pattern.<\/td><\/tr><tr><th scope=\"row\"><a href=\"https:\/\/www.ultalabtests.com\/test\/comprehensive-metabolic-panel-test-cmp\">Comprehensive Metabolic Panel<\/a><br>Common or symptom-directed<\/th><td>Provides selected liver, kidney, electrolyte, protein, calcium, and glucose measures. It may reveal dehydration, metabolic disruption, or an organ-related pattern that changes urgency or next steps.<\/td><td>Cannot see the pancreas, determine whether a mass exists, establish cancer type or stage, or exclude pancreatic cancer when results are normal.<\/td><\/tr><tr><th scope=\"row\"><a href=\"https:\/\/www.ultalabtests.com\/test\/glucose\">Glucose<\/a> and <a href=\"https:\/\/www.ultalabtests.com\/test\/a1c-test\">A1C<\/a><br>Common metabolic context<\/th><td>Show point-in-time and longer-term glycemic patterns. They can confirm that dysglycemia deserves standard evaluation and may be relevant when new metabolic change accompanies other warning symptoms.<\/td><td>Cannot identify why glucose changed or diagnose pancreatic cancer. New diabetes alone does not create a routine tumor-marker or pancreatic-imaging recommendation for every person.<\/td><\/tr><tr><th scope=\"row\"><a href=\"https:\/\/www.ultalabtests.com\/test\/lipase\">Lipase<\/a> and <a href=\"https:\/\/www.ultalabtests.com\/test\/amylase\">Amylase<\/a><br>Acute-care or targeted<\/th><td>May support an acute-pancreatitis assessment when compatible pain, nausea, or vomiting is present. The result belongs with an examination and, when needed, imaging.<\/td><td>Cannot screen for or diagnose pancreatic cancer. Normal enzymes do not rule out a tumor, and elevated enzymes have several pancreatic and nonpancreatic causes.<\/td><\/tr><tr><th scope=\"row\"><a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a><br>Specialist-selected; monitoring<\/th><td>May add context after a pancreaticobiliary abnormality is identified and may provide a baseline or serial marker in selected people with known disease.<\/td><td>Cannot screen average-risk adults, diagnose cancer, locate a tumor, establish stage, or rule out cancer when normal. Biliary obstruction and benign inflammation can raise it, and some people do not produce it.<\/td><\/tr><tr><th scope=\"row\"><a href=\"https:\/\/www.ultalabtests.com\/test\/CEA\">CEA<\/a><br>Specialist-selected; monitoring<\/th><td>May be used as a complementary marker in selected known cancers or specialist-defined evaluations, particularly when a pretreatment baseline is informative.<\/td><td>Cannot serve as general pancreatic-cancer screening or diagnosis. Smoking, liver and digestive conditions, inflammation, and other cancers can affect it.<\/td><\/tr><\/tbody><\/table><figcaption class=\"wp-element-caption\">Blood tests used in pancreatic and biliary evaluation<\/figcaption><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-blood-test-limits.webp?resize=1024%2C768&#038;quality=100&#038;ssl=1\" alt=\"Comparison of what pancreatic blood tests may show versus what they cannot establish without imaging or tissue sampling.\" class=\"wp-image-4050\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-blood-test-limits.webp?resize=1024%2C768&amp;quality=100&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-blood-test-limits.webp?resize=300%2C225&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-blood-test-limits.webp?resize=768%2C576&amp;quality=100&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-blood-test-limits.webp?resize=1536%2C1152&amp;quality=100&amp;ssl=1 1536w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-blood-test-limits.webp?w=1600&amp;quality=100&amp;ssl=1 1600w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"wp-element-caption\">Laboratory tests may reveal bile-flow, blood-count, metabolic, or pancreatic-injury patterns. They cannot locate a mass, confirm cancer, determine stage, or exclude serious disease by themselves.<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">A larger test bundle is not automatically more useful. Ordering multiple nonspecific tumor markers in a low-risk person increases the chance of incidental or false-positive results, anxiety, repeat testing, imaging, and invasive follow-up without creating a validated early-detection pathway.<\/p>\n<\/div><\/section>\n\n\n\n<section id=\"tumor-marker-limits\" class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"tumor-marker-limits-heading\" class=\"wp-block-heading\">Why tumor markers are not screening tests<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a>: useful in selected settings, unreliable as a general screen<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a> is the tumor marker most often associated with pancreatic ductal adenocarcinoma, but association is not the same as screening accuracy. A marker intended for population screening must reliably find important disease early while keeping false-positive results and unnecessary procedures acceptably low. <a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a> does not meet that standard for average-risk adults.<sup><a href=\"#ref-1\" aria-label=\"Reference 1\">[1]<\/a><\/sup><sup><a href=\"#ref-3\" aria-label=\"Reference 3\">[3]<\/a><\/sup><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>False positives occur:<\/strong> bile-duct obstruction, cholangitis, pancreatitis, liver disease, and other benign or malignant conditions can raise the result.<\/li>\n\n\n\n<li><strong>False negatives occur:<\/strong> early or biologically different tumors may not release a measurable amount.<\/li>\n\n\n\n<li><strong>Some people cannot produce the marker:<\/strong> individuals without the necessary Lewis blood-group antigen may have little or no measurable value even when disease is present.<\/li>\n\n\n\n<li><strong>Obstruction changes interpretation:<\/strong> a result obtained during jaundice or blocked bile flow may fall after the obstruction is treated, so one isolated value can be misleading.<\/li>\n\n\n\n<li><strong>Trend purpose must be defined:<\/strong> serial values are most useful when the marker was informative at baseline and the oncology team interprets the trend with imaging and the treatment plan.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.ultalabtests.com\/test\/CEA\">CEA<\/a>: a complementary marker, not a pancreatic-cancer detector<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.ultalabtests.com\/test\/CEA\">CEA<\/a> can be elevated in several cancers and in noncancerous conditions. It has a better-established monitoring role in selected people with colorectal cancer than it does as a pancreatic-cancer marker. In a pancreatic evaluation, a specialist may occasionally use it as complementary information, but a high result does not prove cancer and a normal result does not exclude it.<sup><a href=\"#ref-3\" aria-label=\"Reference 3\">[3]<\/a><\/sup><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/ca-19-9-cea-uses-limits.webp?resize=1024%2C768&#038;quality=100&#038;ssl=1\" alt=\"CA 19-9 and CEA comparison explains selected specialist uses, false-positive causes, and limits as pancreatic cancer screening tests.\" class=\"wp-image-4056\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/ca-19-9-cea-uses-limits.webp?resize=1024%2C768&amp;quality=100&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/ca-19-9-cea-uses-limits.webp?resize=300%2C225&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/ca-19-9-cea-uses-limits.webp?resize=768%2C576&amp;quality=100&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/ca-19-9-cea-uses-limits.webp?resize=1536%2C1152&amp;quality=100&amp;ssl=1 1536w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/ca-19-9-cea-uses-limits.webp?w=1600&amp;quality=100&amp;ssl=1 1600w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"wp-element-caption\">CA 19-9 and CEA may add context in selected specialist-managed situations, but neither is a general pancreatic cancer screening test or a stand-alone diagnosis.<\/figcaption><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Pancreatic enzymes answer a different question<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.ultalabtests.com\/test\/lipase\">Lipase<\/a> and <a href=\"https:\/\/www.ultalabtests.com\/test\/amylase\">amylase<\/a> are enzyme tests used mainly when acute pancreatic injury is suspected. Their job is not to find a pancreatic tumor. A person can have pancreatic cancer with normal enzyme values, and an elevated result is much more often interpreted through the acute-pancreatitis or other-injury pathway. See the separate <a href=\"https:\/\/www.ultalabtests.com\/blog\/digestive-system\/pancreatic-diseases\/understanding-pancreatitis-symptoms-causes-pancreatic-cancer\/\">pancreatitis guide<\/a> for a focused explanation.<sup><a href=\"#ref-6\" aria-label=\"Reference 6\">[6]<\/a><\/sup><\/p>\n<\/div><\/section>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-enzymes-vs-cancer-testing.webp?resize=1024%2C576&#038;quality=100&#038;ssl=1\" alt=\"Lipase, liver tests, imaging, tissue sampling, and tumor markers are matched to the different clinical questions they answer.\" class=\"wp-image-4055\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-enzymes-vs-cancer-testing.webp?resize=1024%2C576&amp;quality=100&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-enzymes-vs-cancer-testing.webp?resize=300%2C169&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-enzymes-vs-cancer-testing.webp?resize=768%2C432&amp;quality=100&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-enzymes-vs-cancer-testing.webp?resize=1536%2C864&amp;quality=100&amp;ssl=1 1536w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-enzymes-vs-cancer-testing.webp?w=1600&amp;quality=100&amp;ssl=1 1600w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"wp-element-caption\">Lipase and amylase mainly support acute pancreatic-injury evaluation. Imaging examines anatomy, and tissue sampling determines whether cancer cells are present when sampling is required.<\/figcaption><\/figure>\n\n\n\n<section class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"new-diabetes-heading\" class=\"wp-block-heading\">What does new diabetes mean in a pancreatic-cancer evaluation?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">New diabetes or unexpectedly worsening glycemia can occur for many reasons and is common in the general population. The right first step is a standard diabetes evaluation using purpose-selected measurements such as <a href=\"https:\/\/www.ultalabtests.com\/test\/glucose\">glucose<\/a> and <a href=\"https:\/\/www.ultalabtests.com\/test\/a1c-test\">A1C<\/a>, interpreted with symptoms, medicines, weight trajectory, and clinical history. See <a href=\"https:\/\/www.ultalabtests.com\/blog\/diabetes\/diabetes-prediabetes-blood-tests\/\">Diabetes and Prediabetes Blood Tests<\/a> for the glycemia pathway.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">New diabetes becomes more concerning when it appears with unexplained weight loss, jaundice, persistent upper-abdominal or back pain, pale or greasy stool, a strong familial or genetic risk, or another abnormal finding. That combination calls for professional evaluation. It does not mean that every newly diagnosed person should order <a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a>, <a href=\"https:\/\/www.ultalabtests.com\/test\/CEA\">CEA<\/a>, or a broad cancer-marker panel on their own.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/new-diabetes-pancreatic-evaluation-1024x576.webp?resize=1024%2C576&#038;quality=100&#038;ssl=1\" alt=\"New or worsening glycemia leads first to glucose, A1C, and clinical review, with escalation when concerning features are present.\" class=\"wp-image-4054\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/new-diabetes-pancreatic-evaluation.webp?resize=1024%2C576&amp;quality=100&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/new-diabetes-pancreatic-evaluation.webp?resize=300%2C169&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/new-diabetes-pancreatic-evaluation.webp?resize=768%2C432&amp;quality=100&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/new-diabetes-pancreatic-evaluation.webp?resize=1536%2C864&amp;quality=100&amp;ssl=1 1536w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/new-diabetes-pancreatic-evaluation.webp?w=1600&amp;quality=100&amp;ssl=1 1600w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"wp-element-caption\">New diabetes is common and usually is not caused by pancreatic cancer. Standard metabolic evaluation comes first, while concerning symptom combinations may justify prompt imaging or specialist referral.<\/figcaption><\/figure>\n<\/div><\/section>\n\n\n\n<section id=\"diagnosis\" class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"diagnosis-heading\" class=\"wp-block-heading\">What usually establishes a pancreatic-cancer diagnosis?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Diagnosis is a coordinated process rather than a single result. The exact sequence depends on symptoms, urgency, imaging findings, whether bile flow is blocked, and whether a lesion appears removable.<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Clinical evaluation:<\/strong> A clinician reviews the symptom timeline, weight change, jaundice, stool and urine changes, pancreatitis or diabetes history, smoking, medicines, personal and family cancer history, and inherited-risk clues. Examination can identify jaundice, dehydration, tenderness, a palpable gallbladder, weight loss, or other findings that change urgency.<\/li>\n\n\n\n<li><strong>Initial laboratory context:<\/strong> A <a href=\"https:\/\/www.ultalabtests.com\/test\/liver-function-panel-test\">Liver Function Panel<\/a>, <a href=\"https:\/\/www.ultalabtests.com\/test\/bilirubin-total\">Bilirubin Total<\/a>, <a href=\"https:\/\/www.ultalabtests.com\/test\/bilirubin-direct-test\">Bilirubin Direct<\/a>, a <a href=\"https:\/\/www.ultalabtests.com\/test\/complete-blood-count-with-differential-and-platelets-cbc-test\">CBC with differential and platelets<\/a>, and a <a href=\"https:\/\/www.ultalabtests.com\/test\/comprehensive-metabolic-panel-test-cmp\">CMP<\/a> may identify complications and help plan imaging or procedures. These results do not establish the tumor.<\/li>\n\n\n\n<li><strong>Pancreas-focused imaging:<\/strong> A contrast-enhanced pancreas-protocol CT is a common central study. MRI with magnetic resonance cholangiopancreatography may further assess the pancreas and ducts or serve when CT is unsuitable. Ultrasound may identify bile-duct dilation or gallstones but can be limited for a deep pancreatic lesion.<\/li>\n\n\n\n<li><strong>Endoscopic ultrasound:<\/strong> EUS places an ultrasound probe close to the pancreas through an endoscope. It can characterize a lesion and guide needle sampling when tissue is required.<\/li>\n\n\n\n<li><strong>Tissue sampling when needed:<\/strong> Cytology or biopsy allows a pathologist to determine whether cancer cells are present and what type they are. The timing and route depend on whether surgery, systemic therapy, or another intervention is planned.<\/li>\n\n\n\n<li><strong>Staging and multidisciplinary review:<\/strong> Radiology, gastroenterology, surgical oncology, medical oncology, pathology, genetics, nutrition, and other specialists may contribute. Imaging and pathology\u2014not a tumor marker alone\u2014define disease extent and treatment options.<sup><a href=\"#ref-2\" aria-label=\"Reference 2\">[2]<\/a><\/sup><\/li>\n<\/ol>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-diagnosis-pathway.webp?resize=1024%2C576&#038;quality=100&#038;ssl=1\" alt=\"Six-step pancreatic cancer evaluation moves from symptoms and blood tests to imaging, endoscopic ultrasound, tissue sampling, and specialist review.\" class=\"wp-image-4048\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-diagnosis-pathway.webp?resize=1024%2C576&amp;quality=100&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-diagnosis-pathway.webp?resize=300%2C169&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-diagnosis-pathway.webp?resize=768%2C432&amp;quality=100&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-diagnosis-pathway.webp?resize=1536%2C864&amp;quality=100&amp;ssl=1 1536w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-diagnosis-pathway.webp?w=1600&amp;quality=100&amp;ssl=1 1600w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"wp-element-caption\">Pancreatic cancer evaluation combines clinical assessment, purpose-selected blood tests, pancreas-focused imaging, and specialist procedures. Imaging and pathology\u2014not a blood test alone\u2014establish the diagnosis.<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">A normal blood panel does not cancel the need for imaging when symptoms or examination remain concerning. Conversely, an abnormal liver or tumor-marker result does not establish cancer without the appropriate diagnostic workup.<\/p>\n<\/div><\/section>\n\n\n\n<section class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"differential-heading\" class=\"wp-block-heading\">Pancreatic cancer, pancreatitis, and biliary disease can overlap<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Upper-abdominal pain, nausea, jaundice, weight loss, and abnormal liver-associated results do not point to one diagnosis. Acute pancreatitis often presents with significant upper-abdominal pain and may raise <a href=\"https:\/\/www.ultalabtests.com\/test\/lipase\">lipase<\/a> or <a href=\"https:\/\/www.ultalabtests.com\/test\/amylase\">amylase<\/a>. Gallstones or another bile-duct obstruction may raise bilirubin and can also cause inflammation. Chronic pancreatitis may cause pain, diabetes, weight loss, and poor digestion. Pancreatic cancer can cause similar symptoms, sometimes by blocking the bile duct or pancreatic duct.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Because these conditions can coexist or mimic one another, the evaluation often combines a <a href=\"https:\/\/www.ultalabtests.com\/test\/liver-function-panel-test\">Liver Function Panel<\/a>, selected pancreatic enzymes, and imaging. The goal is not to choose a laboratory result that \u201cdifferentiates cancer.\u201d The goal is to define the anatomy, identify urgent complications, and obtain tissue when appropriate.<\/p>\n<\/div><\/section>\n\n\n\n<section id=\"high-risk-surveillance\" class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"high-risk-surveillance-heading\" class=\"wp-block-heading\">High-risk pancreatic surveillance is specialist managed<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The recommendation against routine screening applies to average-risk adults without symptoms. It does not define care for people with a strong familial or inherited risk. Selected people with certain pathogenic variants, hereditary syndromes, or a substantial family history may be eligible for surveillance through an experienced high-risk pancreatic program.<sup><a href=\"#ref-1\" aria-label=\"Reference 1\">[1]<\/a><\/sup><sup><a href=\"#ref-4\" aria-label=\"Reference 4\">[4]<\/a><\/sup><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These programs typically use structured risk assessment and specialist-selected imaging, often MRI with MRCP and\/or EUS. The starting age, interval, and modality depend on the gene, family history, prior findings, age, comorbidities, and program protocol. Surveillance may lead to repeat imaging, shorter follow-up, tissue sampling, or surgery at a center experienced in pancreatic disease.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A self-ordered <a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a> or <a href=\"https:\/\/www.ultalabtests.com\/test\/CEA\">CEA<\/a> result is not a substitute for a high-risk program. If you have multiple close relatives with pancreatic cancer, a known inherited cancer-predisposition variant, or a syndrome associated with pancreatic cancer, ask for genetic counseling or referral to an appropriate surveillance center. Observational data suggest that carefully selected high-risk surveillance can identify smaller, earlier-stage cancers, but the evidence and pathway do not support extending the same approach to average-risk adults.<sup><a href=\"#ref-5\" aria-label=\"Reference 5\">[5]<\/a><\/sup><\/p>\n<\/div><\/section>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-high-risk-surveillance.webp?resize=1024%2C576&#038;quality=100&#038;ssl=1\" alt=\"Average-risk adults without symptoms are contrasted with selected inherited or familial risk managed in specialist surveillance programs.\" class=\"wp-image-4053\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-high-risk-surveillance.webp?resize=1024%2C576&amp;quality=100&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-high-risk-surveillance.webp?resize=300%2C169&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-high-risk-surveillance.webp?resize=768%2C432&amp;quality=100&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-high-risk-surveillance.webp?resize=1536%2C864&amp;quality=100&amp;ssl=1 1536w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-high-risk-surveillance.webp?w=1600&amp;quality=100&amp;ssl=1 1600w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"wp-element-caption\">Routine pancreatic cancer screening is not recommended for average-risk adults without symptoms. Selected people with inherited or familial risk may qualify for specialist-managed MRI\/MRCP or EUS surveillance.<\/figcaption><\/figure>\n\n\n\n<section id=\"preparation\" class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"preparation-heading\" class=\"wp-block-heading\">Preparation, timing, and common result influences<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Preparation depends on the exact test and everything else included in the order. Do not stop a prescribed medicine, supplement, diabetes treatment, or anticoagulant solely for testing unless the prescribing clinician gives explicit instructions.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th scope=\"col\">Test<\/th><th scope=\"col\">Preparation<\/th><th scope=\"col\">Important influences<\/th><\/tr><\/thead><tbody><tr><th scope=\"row\"><a href=\"https:\/\/www.ultalabtests.com\/test\/complete-blood-count-with-differential-and-platelets-cbc-test\">CBC with differential and platelets<\/a><\/th><td>Fasting is usually unnecessary when ordered alone.<\/td><td>Hydration, recent illness, inflammation, bleeding, altitude, pregnancy, medicines, and treatment timing can affect the pattern.<\/td><\/tr><tr><th scope=\"row\"><a href=\"https:\/\/www.ultalabtests.com\/test\/comprehensive-metabolic-panel-test-cmp\">CMP<\/a> or <a href=\"https:\/\/www.ultalabtests.com\/test\/liver-function-panel-test\">Liver Function Panel<\/a><\/th><td>Follow the instructions for the full order; an accompanying measurement may require fasting.<\/td><td>Hydration, alcohol, acute illness, exercise, medicines, supplements, specimen hemolysis, and bile-duct obstruction can change results.<\/td><\/tr><tr><th scope=\"row\"><a href=\"https:\/\/www.ultalabtests.com\/test\/glucose\">Glucose<\/a> and <a href=\"https:\/\/www.ultalabtests.com\/test\/a1c-test\">A1C<\/a><\/th><td>A diagnostic fasting glucose requires at least eight hours without calories; <a href=\"https:\/\/www.ultalabtests.com\/test\/a1c-test\">A1C<\/a> generally does not require fasting.<\/td><td>Acute illness, stress, steroids and other medicines can change glucose. Anemia, blood loss, transfusion, red-cell turnover, kidney disease, pregnancy, and some hemoglobin variants can affect <a href=\"https:\/\/www.ultalabtests.com\/test\/a1c-test\">A1C<\/a>.<\/td><\/tr><tr><th scope=\"row\"><a href=\"https:\/\/www.ultalabtests.com\/test\/lipase\">Lipase<\/a> and <a href=\"https:\/\/www.ultalabtests.com\/test\/amylase\">Amylase<\/a><\/th><td>Use symptom-directed timing and follow the exact order instructions. Severe pain or vomiting requires clinical assessment, not preparation for routine testing.<\/td><td>Time from symptom onset, kidney function, salivary disease, gallstones, alcohol, medicines, triglyceride concentration, and other illnesses can affect interpretation.<\/td><\/tr><tr><th scope=\"row\"><a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a> and <a href=\"https:\/\/www.ultalabtests.com\/test\/CEA\">CEA<\/a><\/th><td>Use only for a defined professional question; repeat testing should ideally use the same laboratory and method when trends matter.<\/td><td>Jaundice and bile-duct obstruction are major influences on <a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a>. Smoking and several benign inflammatory, liver, and digestive conditions can affect <a href=\"https:\/\/www.ultalabtests.com\/test\/CEA\">CEA<\/a>. Treatment and assay changes can disrupt trends.<\/td><\/tr><\/tbody><\/table><figcaption class=\"wp-element-caption\">Preparation and interpretation factors for commonly discussed tests<\/figcaption><\/figure>\n<\/div><\/section>\n\n\n\n<section id=\"results\" class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"results-heading\" class=\"wp-block-heading\">How to understand results without over-interpreting them<\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Start with the reason for testing.<\/strong> A result ordered for acute pain, jaundice, a known diagnosis, treatment monitoring, or general metabolic assessment has a different meaning.<\/li>\n\n\n\n<li><strong>Check units, reference information, and flags.<\/strong> A flagged value is not automatically dangerous, and a value inside the laboratory interval is not proof that serious disease is absent.<\/li>\n\n\n\n<li><strong>Read patterns rather than isolated values.<\/strong> Bilirubin and liver-associated results together may suggest impaired bile flow. A blood count plus chemistry pattern may reveal dehydration, anemia, or organ stress. The pattern still requires a cause.<\/li>\n\n\n\n<li><strong>Account for timing and confounders.<\/strong> Meals, fasting, acute illness, hydration, medicines, smoking, obstruction, specimen quality, and assay method can matter.<\/li>\n\n\n\n<li><strong>Separate diagnosis from monitoring.<\/strong> A tumor marker that helps follow known disease does not become a valid screening test for someone without a diagnosis.<\/li>\n\n\n\n<li><strong>Compare trends carefully.<\/strong> Use like-with-like measurements from the same method when possible, and review what changed between collections.<\/li>\n\n\n\n<li><strong>Choose the next action.<\/strong> Depending on the situation, that may be urgent care, repeat laboratory testing, ultrasound, CT, MRI, EUS, gastroenterology review, oncology follow-up, or no immediate action.<\/li>\n<\/ol>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-lab-results-framework.webp?resize=1024%2C768&#038;quality=100&#038;ssl=1\" alt=\"Seven-step framework for interpreting pancreatic and biliary laboratory results by purpose, patterns, influences, trends, and next action.\" class=\"wp-image-4052\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-lab-results-framework.webp?resize=1024%2C768&amp;quality=100&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-lab-results-framework.webp?resize=300%2C225&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-lab-results-framework.webp?resize=768%2C576&amp;quality=100&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-lab-results-framework.webp?resize=1536%2C1152&amp;quality=100&amp;ssl=1 1536w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-lab-results-framework.webp?w=1600&amp;quality=100&amp;ssl=1 1600w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"wp-element-caption\">Interpret results by purpose, units, related patterns, result influences, test role, comparable trends, and the next clinical action. A flagged value is not a diagnosis, and a normal result does not exclude serious disease.<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">For a structured approach to reference intervals, flags, thresholds, units, and serial changes, use <a href=\"https:\/\/www.ultalabtests.com\/blog\/lab-testing-knowledge-center\/how-to-read-lab-results\/\">How to Read and Understand Your Lab Results<\/a>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">What not to conclude<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>A normal <a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a> does not rule out pancreatic cancer.<\/li>\n\n\n\n<li>A high <a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a> or <a href=\"https:\/\/www.ultalabtests.com\/test\/CEA\">CEA<\/a> does not prove cancer.<\/li>\n\n\n\n<li>Elevated <a href=\"https:\/\/www.ultalabtests.com\/test\/lipase\">lipase<\/a> or <a href=\"https:\/\/www.ultalabtests.com\/test\/amylase\">amylase<\/a> does not establish a pancreatic tumor.<\/li>\n\n\n\n<li>Normal liver-associated tests do not exclude a pancreatic lesion.<\/li>\n\n\n\n<li>A new diabetes diagnosis does not automatically mean pancreatic cancer.<\/li>\n\n\n\n<li>No blood panel can determine whether a tumor is surgically removable or establish its stage.<\/li>\n<\/ul>\n<\/div><\/section>\n\n\n\n<section class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"when-not-to-order-heading\" class=\"wp-block-heading\">When self-directed blood testing is the wrong next step<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Emergency symptoms:<\/strong> severe pain, jaundice with fever, repeated vomiting, dehydration, fainting, confusion, or bleeding require immediate clinical assessment.<\/li>\n\n\n\n<li><strong>Average-risk screening without symptoms:<\/strong> a broad tumor-marker panel is not a validated pancreatic-cancer screening strategy.<\/li>\n\n\n\n<li><strong>Persistent warning symptoms after normal labs:<\/strong> do not keep repeating blood panels instead of arranging an examination and appropriate imaging.<\/li>\n\n\n\n<li><strong>A new mass or abnormal scan:<\/strong> specialist review and tissue planning are more important than adding multiple nonspecific markers.<\/li>\n\n\n\n<li><strong>Known pancreatic cancer:<\/strong> monitoring intervals and markers should come from the oncology plan, not a fixed consumer package.<\/li>\n\n\n\n<li><strong>Strong hereditary risk:<\/strong> surveillance eligibility, imaging modality, and interval belong in a genetics-informed high-risk program.<\/li>\n<\/ul>\n<\/div><\/section>\n\n\n\n<section class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"questions-heading\" class=\"wp-block-heading\">Questions to ask your clinician<\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Which features of my symptoms make this urgent or nonurgent?<\/li>\n\n\n\n<li>Could a gallstone, liver condition, pancreatitis, medication, ulcer, or metabolic disorder explain the same pattern?<\/li>\n\n\n\n<li>Do I need a pancreas-protocol CT, MRI\/MRCP, ultrasound, or endoscopic ultrasound?<\/li>\n\n\n\n<li>What question would each blood test answer, and what could it not rule out?<\/li>\n\n\n\n<li>If bilirubin is high, is there evidence of blocked bile flow and does it need urgent treatment?<\/li>\n\n\n\n<li>If a tumor marker is being considered, will the result change the imaging, biopsy, or treatment plan?<\/li>\n\n\n\n<li>Could jaundice, inflammation, smoking, or another condition be influencing the marker?<\/li>\n\n\n\n<li>Is tissue sampling needed, and what is the safest route and timing?<\/li>\n\n\n\n<li>Does my family history justify genetic counseling or referral to a high-risk surveillance program?<\/li>\n\n\n\n<li>Which symptoms should send me to urgent care before my next scheduled appointment?<\/li>\n<\/ol>\n<\/div><\/section>\n\n\n\n<section id=\"faq\" class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"faq-heading\" class=\"wp-block-heading\">Frequently asked questions<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Can a blood test detect pancreatic cancer early?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">No routine blood test reliably detects early pancreatic cancer in the general population. A blood result may identify a complication or add context, but dedicated imaging and sometimes tissue sampling are required to establish the diagnosis.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Is <a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a> a pancreatic-cancer screening test?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">No. <a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a> can be elevated by benign bile-duct obstruction and inflammation, may remain normal in pancreatic cancer, and is not produced by some people. It is best reserved for a specialist-defined evaluation or monitoring role.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Does a high <a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a> mean I have cancer?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">No. The result must be interpreted with jaundice status, liver-associated results, symptoms, imaging, treatment history, and the trend. A blocked bile duct can substantially raise the marker without establishing cancer.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Can a normal <a href=\"https:\/\/www.ultalabtests.com\/test\/ca-19-9\">CA 19-9<\/a> rule out pancreatic cancer?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">No. Some tumors do not release a measurable amount, early disease may not raise it, and some people biologically cannot produce the marker. Persistent warning symptoms still require evaluation.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">What is the role of <a href=\"https:\/\/www.ultalabtests.com\/test\/CEA\">CEA<\/a>?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.ultalabtests.com\/test\/CEA\">CEA<\/a> may provide complementary information in selected known cancers or specialist-directed evaluations. It is nonspecific and should not be used as stand-alone pancreatic-cancer screening or diagnosis.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Do <a href=\"https:\/\/www.ultalabtests.com\/test\/lipase\">lipase<\/a> and <a href=\"https:\/\/www.ultalabtests.com\/test\/amylase\">amylase<\/a> detect pancreatic cancer?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">No. They mainly support evaluation of acute pancreatic injury when symptoms are compatible. Pancreatic cancer can be present with normal enzyme values, and elevations have many other causes.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Why are bilirubin and liver-associated tests ordered?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">A <a href=\"https:\/\/www.ultalabtests.com\/test\/liver-function-panel-test\">Liver Function Panel<\/a>, <a href=\"https:\/\/www.ultalabtests.com\/test\/bilirubin-total\">Bilirubin Total<\/a>, or <a href=\"https:\/\/www.ultalabtests.com\/test\/bilirubin-direct-test\">Bilirubin Direct<\/a> may reveal a pattern compatible with impaired bile flow. The tests cannot show whether the cause is a stone, inflammation, stricture, medication, liver disease, or tumor; imaging usually answers the structural question.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Should everyone with new diabetes get pancreatic-cancer blood tests?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">No. New diabetes is common and should receive standard metabolic evaluation. Unexplained weight loss, jaundice, progressive pain, a strong family history, or another concerning finding may change the workup, but a new diagnosis alone does not justify routine tumor-marker screening.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">What test most often finds a pancreatic mass?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Dedicated imaging is central. A pancreas-protocol CT is commonly used, with MRI\/MRCP, EUS, or other procedures selected according to the clinical situation. A biopsy may be needed to establish tumor type.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Who should consider high-risk surveillance?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Selected people with a substantial family history, a qualifying inherited variant, or a pancreatic-cancer predisposition syndrome may be eligible. A genetics-informed pancreatic surveillance program should define eligibility, starting age, imaging method, and interval.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Can direct-access testing replace a clinician visit?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">No. Direct-access testing can provide selected laboratory information for stable, appropriate questions, but it cannot perform an examination, order or interpret emergency imaging, relieve an obstruction, obtain tissue, or coordinate cancer care. Review <a href=\"https:\/\/www.ultalabtests.com\/blog\/lab-testing-knowledge-center\/direct-access-lab-testing\/\">Direct-Access Lab Testing: How It Works and What to Expect<\/a> before ordering.<\/p>\n<\/div><\/section>\n\n\n\n<section class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"ulta-heading\" class=\"wp-block-heading\">How Ulta Lab Tests can fit into responsible evaluation<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ulta Lab Tests provides access to selected laboratory tests discussed in this article. These tests are most useful when the clinical question is clear and the result will lead to an appropriate next step. They do not replace urgent care, imaging, EUS, biopsy, pathology, genetic counseling, or specialist management.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If warning symptoms are present, arrange medical evaluation first. If a clinician has recommended a specific laboratory measurement, use the linked test page to confirm the current specimen, preparation, availability, and product details before purchase. Do not substitute a broad tumor-marker package for a defined diagnostic or monitoring plan.<\/p>\n<\/div><\/section>\n\n\n\n<section class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"conclusion-heading\" class=\"wp-block-heading\">The bottom line<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Pancreatic-cancer symptoms are often nonspecific, and blood tests cannot reliably detect or exclude the disease on their own. Laboratory testing is most valuable when it identifies complications, supports a focused differential, or monitors a known diagnosis. New jaundice, unexplained weight loss, persistent upper-abdominal or back pain, pale or greasy stool, and concerning metabolic change deserve timely professional evaluation. When pancreatic cancer is possible, dedicated imaging\u2014and sometimes EUS and tissue sampling\u2014moves the diagnosis forward.<\/p>\n<\/div><\/section>\n\n\n\n<section class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"references-heading\" class=\"wp-block-heading\">References<\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li id=\"ref-1\"><a href=\"https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/pancreatic-cancer-screening\">U.S. Preventive Services Task Force. Pancreatic Cancer: Screening.<\/a> Final recommendation statement.<\/li>\n\n\n\n<li id=\"ref-2\"><a href=\"https:\/\/www.cancer.gov\/types\/pancreatic\/patient\/pancreatic-treatment-pdq\">National Cancer Institute. Pancreatic Cancer Treatment (PDQ\u00ae)\u2014Patient Version.<\/a><\/li>\n\n\n\n<li id=\"ref-3\"><a href=\"https:\/\/www.cancer.gov\/about-cancer\/diagnosis-staging\/diagnosis\/tumor-markers-list\">National Cancer Institute. Tumor Marker Tests in Common Use.<\/a><\/li>\n\n\n\n<li id=\"ref-4\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31672839\/\">Goggins M, et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening Consortium. Gut. 2020.<\/a><\/li>\n\n\n\n<li id=\"ref-5\"><a href=\"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2820691\">Blackford AL, et al. Pancreatic Cancer Surveillance and Survival of High-Risk Individuals. JAMA Oncology. 2024.<\/a><\/li>\n\n\n\n<li id=\"ref-6\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38857482\/\">Tenner S, et al. American College of Gastroenterology Guidelines: Management of Acute Pancreatitis. American Journal of Gastroenterology. 2024.<\/a><\/li>\n<\/ol>\n<\/div><\/section>\n\n\n\n<section class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 id=\"disclosure-heading\" class=\"wp-block-heading\">Disclosure and update history<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Commercial disclosure:<\/strong> Ulta Lab Tests sells direct-access laboratory testing. Product links are provided for convenience and do not mean that every test is appropriate for every reader. This educational article does not diagnose disease or replace care from a qualified health professional.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Originally published:<\/strong> August 8, 2025 | <strong>Substantively updated:<\/strong> September 2, 2026<\/p>\n<\/div><\/section>\n","protected":false},"excerpt":{"rendered":"<p>Direct answer: No routine blood test can reliably screen the general population for pancreatic cancer, diagnose it by itself, or rule it out. Blood tests can reveal jaundice-related bile-flow abnormalities, anemia, metabolic changes, or pancreatic [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":4059,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[62,90,72,99,200],"tags":[1652,5900,5901,5902,5904,1651,5903,1649,1653,1349],"class_list":["post-2139","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","category-digestive-system","category-pancreatic-cancer","category-pancreatic-diseases","category-pancreatitis","tag-ca-19-9","tag-cea","tag-high-risk-pancreatic-surveillance","tag-jaundice","tag-pancreatic-cancer","tag-pancreatic-cancer-blood-tests","tag-pancreatic-cancer-screening-limitations","tag-pancreatic-cancer-symptoms","tag-pancreatitis-tests","tag-tumor-markers"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Pancreatic Cancer Symptoms and Testing: What Blood Tests Can\u2014and Cannot Detect | Ulta Lab Tests<\/title>\n<meta name=\"description\" content=\"Learn how pancreatic cancer blood tests, pancreatic cancer symptoms, and the CA 19-9 test support evaluation\u2014and why their limits matter most.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pancreatic Cancer Symptoms and Testing: What Blood Tests Can\u2014and Cannot Detect\" \/>\n<meta property=\"og:description\" content=\"Learn how pancreatic cancer blood tests, pancreatic cancer symptoms, and the CA 19-9 test support evaluation\u2014and why their limits matter most.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/\" \/>\n<meta property=\"og:site_name\" content=\"Ulta Lab Tests\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/ultalabtests\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-02T19:52:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-02T19:52:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-testing-social.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"John R\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"John R\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"22 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pancreatic Cancer Symptoms and Testing: What Blood Tests Can\u2014and Cannot Detect | Ulta Lab Tests","description":"Learn how pancreatic cancer blood tests, pancreatic cancer symptoms, and the CA 19-9 test support evaluation\u2014and why their limits matter most.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/","og_locale":"en_US","og_type":"article","og_title":"Pancreatic Cancer Symptoms and Testing: What Blood Tests Can\u2014and Cannot Detect","og_description":"Learn how pancreatic cancer blood tests, pancreatic cancer symptoms, and the CA 19-9 test support evaluation\u2014and why their limits matter most.","og_url":"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/","og_site_name":"Ulta Lab Tests","article_publisher":"https:\/\/facebook.com\/ultalabtests","article_published_time":"2026-09-02T19:52:52+00:00","article_modified_time":"2026-09-02T19:52:55+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-testing-social.webp","type":"image\/webp"}],"author":"John R","twitter_card":"summary_large_image","twitter_misc":{"Written by":"John R","Est. reading time":"22 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/#article","isPartOf":{"@id":"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/"},"author":{"name":"John R","@id":"https:\/\/www.ultalabtests.com\/blog\/#\/schema\/person\/e9af1f4fe34b68909911dc95c313ed6a"},"headline":"Pancreatic Cancer Symptoms and Testing: What Blood Tests Can\u2014and Cannot Detect","datePublished":"2026-09-02T19:52:52+00:00","dateModified":"2026-09-02T19:52:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/"},"wordCount":4360,"publisher":{"@id":"https:\/\/www.ultalabtests.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-testing-social.webp?fit=1200%2C1200&quality=100&ssl=1","keywords":["CA 19-9","CEA","high-risk pancreatic surveillance","jaundice","pancreatic cancer","pancreatic cancer blood tests","pancreatic cancer screening limitations","pancreatic cancer symptoms","pancreatitis tests","tumor markers"],"articleSection":["Cancer","Digestive System","Pancreatic Cancer","Pancreatic Diseases","Pancreatitis"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/","url":"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/","name":"Pancreatic Cancer Symptoms and Testing: What Blood Tests Can\u2014and Cannot Detect | Ulta Lab Tests","isPartOf":{"@id":"https:\/\/www.ultalabtests.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/#primaryimage"},"image":{"@id":"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-testing-social.webp?fit=1200%2C1200&quality=100&ssl=1","datePublished":"2026-09-02T19:52:52+00:00","dateModified":"2026-09-02T19:52:55+00:00","description":"Learn how pancreatic cancer blood tests, pancreatic cancer symptoms, and the CA 19-9 test support evaluation\u2014and why their limits matter most.","breadcrumb":{"@id":"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/#primaryimage","url":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-testing-social.webp?fit=1200%2C1200&quality=100&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-testing-social.webp?fit=1200%2C1200&quality=100&ssl=1","width":1200,"height":1200,"caption":"Pancreatic evaluation may combine symptoms, blood-test context, dedicated imaging, and specialist review; no blood test works as a stand-alone diagnosis."},{"@type":"BreadcrumbList","@id":"https:\/\/www.ultalabtests.com\/blog\/cancer\/key-symptoms-of-pancreatic-cancer-to-watch-for\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Ulta Lab Tests","item":"https:\/\/www.ultalabtests.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Cancer","item":"https:\/\/www.ultalabtests.com\/blog\/category\/cancer\/"},{"@type":"ListItem","position":3,"name":"Pancreatic Cancer Symptoms and Testing: What Blood Tests Can\u2014and Cannot Detect"}]},{"@type":"WebSite","@id":"https:\/\/www.ultalabtests.com\/blog\/#website","url":"https:\/\/www.ultalabtests.com\/blog\/","name":"Ulta Lab Tests","description":"You Order the Test. We&#039;ll Do the Rest!","publisher":{"@id":"https:\/\/www.ultalabtests.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ultalabtests.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ultalabtests.com\/blog\/#organization","name":"Ulta Lab Tests","url":"https:\/\/www.ultalabtests.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ultalabtests.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2023\/02\/logo.png?fit=405%2C79&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2023\/02\/logo.png?fit=405%2C79&ssl=1","width":405,"height":79,"caption":"Ulta Lab Tests"},"image":{"@id":"https:\/\/www.ultalabtests.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/ultalabtests","http:\/\/www.linkedin.com\/company\/3335617"]},{"@type":"Person","@id":"https:\/\/www.ultalabtests.com\/blog\/#\/schema\/person\/e9af1f4fe34b68909911dc95c313ed6a","name":"John R","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d48f9c8356694121fd9e2793e13d6aa6855e5df11f9b14f7a872b4ea554581fb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d48f9c8356694121fd9e2793e13d6aa6855e5df11f9b14f7a872b4ea554581fb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d48f9c8356694121fd9e2793e13d6aa6855e5df11f9b14f7a872b4ea554581fb?s=96&d=mm&r=g","caption":"John R"}}]}},"featured_image_src":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-testing-social.webp?resize=600%2C400&quality=100&ssl=1","featured_image_src_square":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-testing-social.webp?resize=600%2C600&quality=100&ssl=1","author_info":{"display_name":"John R","author_link":"https:\/\/www.ultalabtests.com\/blog\/author\/johnroehmultalabtests-com\/"},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2025\/08\/pancreatic-cancer-testing-social.webp?fit=1200%2C1200&quality=100&ssl=1","_links":{"self":[{"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/posts\/2139","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/comments?post=2139"}],"version-history":[{"count":0,"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/posts\/2139\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/media\/4059"}],"wp:attachment":[{"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/media?parent=2139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/categories?post=2139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/tags?post=2139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}